Core Laboratories (NYSE:CLB – Get Free Report) is expected to post its quarterly earnings results after the market closes on Wednesday, January 29th. Analysts expect Core Laboratories to post earnings of $0.23 per share and revenue of $133,349.57 billion for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Core Laboratories Trading Down 2.5 %
Shares of CLB stock opened at $19.02 on Tuesday. The stock has a market capitalization of $892.75 million, a P/E ratio of 29.25, a price-to-earnings-growth ratio of 1.14 and a beta of 2.39. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $25.13. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The company has a 50 day moving average price of $19.07 and a 200 day moving average price of $19.52.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on CLB. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup decreased their price objective on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $17.00.
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
- Five stocks we like better than Core Laboratories
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Sizing Up a New Opportunity for NVIDIA Investors
- What is MarketRank™? How to Use it
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- The Significance of Brokerage Rankings in Stock Selection
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.